FORMA Therapeutics, Inc. Appoints Dr. Rob Sarisky to Chief Business Officer

Published: Sep 05, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics announced today that Rob Sarisky, Ph.D. has been appointed Chief Business Officer. Dr. Sarisky is an experienced scientific and business professional from the pharmaceutical industry, most recently serving as Vice President of Oncology Business Development and Licensing within Janssen Pharmaceuticals, a Johnson & Johnson company.

Back to news